Search Results - "H.-E. Gerlach"

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study by RIESS, H., HAAS, S., TEBBE, U., GERLACH, H.‐E., ABLETSHAUSER, C., SIEDER, C., ROSSOL, S., PFEIFFER, B., SCHELLONG, S. M.

“…Background: In medically ill patients, no contemporary double‐blind head‐to‐head evaluation of low molecular weight heparin vs. unfractionated heparin (UFH)…”
Get full text

Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study by Schellong, S.M, Gerlach, H.-E, Tebbe, U, Haas, S, Melzer, N, Abletshauser, C, Sieder, C, Bramlage, P, Riess, H, Bauersachs, R

“…Abstract Introduction There is an exponential rise of thromboembolic risk with age because of co-morbidities, immobility and pharmacotherapy. We aimed to…”
Get full text

Implementation of Outpatient Treatment of Deep-vein Thrombosis in Private Practices in Germany by Blättler, W., Gerlach, H.E.

“…Implementation of outpatient treatment (OT) of deep-vein thrombosis (DVT) is slow despite clear evidence that it is effective, safe and cost-efficient. An…”
Get full text

CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency by Bauersachs, R, Schellong, S M, Haas, S, Tebbe, U, Gerlach, H-E, Abletshauser, C, Sieder, C, Melzer, N, Bramlage, P, Riess, H

“…Patients with severe renal insufficiency (sRI) have been suggested to be at an increased risk of bleeding with low-molecular-weight heparins (LMWH). We aimed…”
Get more information

Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime by WASHINGTON, J. A, JONES, R. N, GERLACH, E. H, MURRAY, P. R, ALLEN, S. D, KNAPP, C. C

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid by BARRY, A. L, JONES, R. N, THORNSBERRY, C, AYERS, L. W, GERLACH, E. H, SOMMERS, H. M

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Sucralfate significantly reduces ciprofloxacin concentrations in serum by GARRELTS, J. C, GODLEY, P. J, PETERIE, J. D, GERLACH, E. H, YAKSHE, C. C

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1 by DOERN, G. V, JONES, R. N, GERLACH, E. H, WASHINGTON, J. A, BIEDENBACH, D. J, BRUEGGEMANN, A, ERWIN, M. E, KNAPP, C, RAYMOND, J

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline by JONES, R. N, GAVAN, T. L, THORNSBERRY, C, FUCHS, P. C, GERLACH, E. H, KNAPP, J. S, MURRAY, P, WASHINGTON, J. A. II

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates by Fuchs, P C, Barry, A L, Pfaller, M A, Allen, S D, Gerlach, E H

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative by Hoover, W W, Gerlach, E H, Hoban, D J, Eliopoulos, G M, Pfaller, M A, Jones, R N

“…Rifaximin, a rifamycin derivative, was evaluated in vitro to assess its spectrum and potency against a wide variety of bacteria, yeasts, viruses, and…”
Get more information

Multicenter in vitro evaluation of SM-7338, a new carbapenem by JONES, R. N, ALDRIDGE, K. E, ALLEN, S. D, BARRY, A. L, FUCHS, P. C, GERLACH, E. H, PFALLER, M. A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa by McLaughlin, J C, Barry, A L, Fuchs, P C, Gerlach, E H, Hardy, D J, Pfaller, M A

“…Susceptibility tests were performed on 2402 of consecutive isolates of Enterobacteriaceae and 254 strains of Pseudomonas aeruginosa in five separate medical…”
Get more information

Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin by BALE, M. J, JONES, R. N, ERWIN, M. E, KOONTZ, F. P, GERLACH, E. H, MURRAY, P. R, WASHINGTON, J. A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam by PFALLER, M. A, BARRY, A. L, FUCHS, P. C, GERLACH, E. H, HARDY, D. J, MCLAUGHLIN, J. C

“…Ampicillin combined with sulbactam was tested at both fixed ratio (2:1 and 1:1) and fixed sulbactam concentrations (4 micrograms/ml, 8 micrograms/ml and 16…”
Get full text

Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil, and cefixime when testing Haemophilus influenzae on haemophilus test medium by DOERN, G. V, JONES, R. N, GERLACH, E. H, HINDLER, J, ST. AMAND, R

“…The aim of the current five-center collaborative study was to reassess the interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime previously…”
Get full text

MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin by Bale, M J, Jones, R N, Erwin, M E, Koontz, F P, Gerlach, E H, Murray, P R, Washington, J A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine by BARRY, A. L, PFALLER, M. A, FUCHS, P. C, TENOVER, F. C, RELLER, L. B, ALLEN, S. D, HARDY, D. J, GERLACH, E. H

“…Studies with fosfomycin tromethamine disks containing 200 micrograms of fosfomycin and 50 micrograms of glucose-6-phosphate confirmed the following zone…”
Get full text

Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae by Barry, A L, Fuchs, P C, Gerlach, E H, Hardy, D J, McLaughlin, J C, Pfaller, M A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates by WASHINGTON, J. A, JONES, R. N, ALLEN, S. D, GERLACH, E. H, KOONTZ, F. P, MURRAY, P. R, PFALLER, M. A, ERWIN, M. E

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text